Ocuphire Pharma Files Shelf for Up to $125 Million in Securities, About 7 Million Common Shares From Selling Stockholders
03:52 AM EST, 02/05/2021 (MT Newswires) -- Ocuphire Pharma (OCUP) on Thursday filed a registration statement covering the potential sale of $125 million in securities to be offered by the company and up to 6,987,400 common shares to be offered by certain selling stockholders.
The securities, which may be offered from time to time, include common shares, preferred shares, debt securities, and warrants, according to a filing with the US Securities and Exchange Commission.
The company said it plans to use the net proceeds for working capital and general corporate purposes. It will not receive any proceeds from the sale of the shares being offered by the selling stockholders.
Price: 12.00, Change: -1.31, Percent Change: -9.84